{
    "clinical_study": {
        "@rank": "158089", 
        "arm_group": [
            {
                "arm_group_label": "Arm I (PCPI)", 
                "arm_group_type": "Experimental", 
                "description": "Patients undergo a comprehensive physical, psychological, social, and spiritual palliative care assessment. Patients also receive a workbook that covers physical and psychological well-being and social and spiritual well-being, delivered over 2 educational sessions."
            }, 
            {
                "arm_group_label": "Arm II (standard care plus attention control)", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients receive standard care plus attention comprising two telephone contacts."
            }
        ], 
        "brief_summary": {
            "textblock": "This randomized clinical trial studies palliative care in improving quality of life and\n      symptoms in patients with stage III-IV pancreatic or ovarian cancer. Palliative therapy may\n      help patients with advanced pancreatic or ovarian cancer live more comfortably."
        }, 
        "brief_title": "Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer", 
        "condition": [
            "Recurrent Ovarian Epithelial Cancer", 
            "Recurrent Ovarian Germ Cell Tumor", 
            "Recurrent Pancreatic Cancer", 
            "Stage III Pancreatic Cancer", 
            "Stage IIIA Ovarian Epithelial Cancer", 
            "Stage IIIA Ovarian Germ Cell Tumor", 
            "Stage IIIB Ovarian Epithelial Cancer", 
            "Stage IIIB Ovarian Germ Cell Tumor", 
            "Stage IIIC Ovarian Epithelial Cancer", 
            "Stage IIIC Ovarian Germ Cell Tumor", 
            "Stage IV Ovarian Epithelial Cancer", 
            "Stage IV Ovarian Germ Cell Tumor", 
            "Stage IV Pancreatic Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Ovarian Neoplasms", 
                "Pancreatic Neoplasms", 
                "Neoplasms, Germ Cell and Embryonal", 
                "Germinoma", 
                "Neoplasms, Glandular and Epithelial"
            ]
        }, 
        "detailed_description": {
            "textblock": "PRIMARY OBJECTIVES:\n\n      I. Test the effects of a concurrent palliative care planning intervention (PCPI) on overall\n      quality of life (QOL) and symptom burden.\n\n      II. Test the effects of a concurrent PCPI on anxiety and depression. III. Test the effects\n      of a concurrent PCPI on overall survival. IV. Test the effects of a concurrent PCPI on\n      health care resource use.\n\n      OUTLINE: Patients are randomized to 1 of 2 arms.\n\n      ARM I: Patients undergo a comprehensive physical, psychological, social, and spiritual\n      palliative care assessment. Patients also receive a workbook that covers physical and\n      psychological well-being and social and spiritual well-being, delivered over 2 educational\n      sessions.\n\n      ARM II: Patients receive standard care plus attention comprising two telephone contacts.\n\n      After completion of study, patients are followed up at 1, 3, and 6 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of pancreatic or ovarian cancer\n\n          -  Confirmed stage III or IV disease\n\n          -  Patients who are within one year from initial diagnosis\n\n          -  Able to read or understand English-this is included because most of the\n             patient-reported outcome measures are not validated in linguistically diverse\n             populations; the intent is to adapt and test the intervention in a future study with\n             linguistically diverse populations\n\n          -  Ability to read and/or understand the study protocol requirements, and provide\n             written informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "484", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01927393", 
            "org_study_id": "13270", 
            "secondary_id": [
                "NCI-2013-01629", 
                "13270", 
                "P30CA033572"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Arm I (PCPI)", 
                "description": "Receive PCPI", 
                "intervention_name": "palliative care", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Arm I (PCPI)", 
                "description": "Receive education sessions", 
                "intervention_name": "educational intervention", 
                "intervention_type": "Behavioral", 
                "other_name": "intervention, educational"
            }, 
            {
                "arm_group_label": [
                    "Arm I (PCPI)", 
                    "Arm II (standard care plus attention control)"
                ], 
                "description": "Ancillary studies", 
                "intervention_name": "quality-of-life assessment", 
                "intervention_type": "Procedure", 
                "other_name": "quality of life assessment"
            }, 
            {
                "arm_group_label": [
                    "Arm I (PCPI)", 
                    "Arm II (standard care plus attention control)"
                ], 
                "description": "Ancillary studies", 
                "intervention_name": "questionnaire administration", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Arm II (standard care plus attention control)", 
                "description": "Receive telephone contacts", 
                "intervention_name": "telephone-based intervention", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 28, 2014", 
        "location": {
            "contact": {
                "email": "vsun@coh.org", 
                "last_name": "Virginia Sun", 
                "phone": "800-826-4673"
            }, 
            "facility": {
                "address": {
                    "city": "Duarte", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "91010"
                }, 
                "name": "City of Hope Medical Center"
            }, 
            "investigator": {
                "last_name": "Virginia Sun", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Integration of Palliative Care Planning in Pancreatic and Ovarian Cancers", 
        "overall_official": {
            "affiliation": "City of Hope Medical Center", 
            "last_name": "Virginia Sun", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "The analysis will be a 2x2x3 repeated measures analysis of covariance (ANCOVA) statistical design.", 
                "measure": "Overall QOL, assessed by the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) or the Functional Assessment of Cancer Therapy-Ovarian (FACT-O)", 
                "safety_issue": "No", 
                "time_frame": "Up to 6 months"
            }, 
            {
                "description": "Compared between groups and by diagnoses using two-way contingency table analysis, two way analysis of variance (ANOVA) according to level of measurement.", 
                "measure": "Symptom burden using the FACT-Trial Outcome Index (TOI)", 
                "safety_issue": "No", 
                "time_frame": "Up to 6 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01927393"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Compared demographically by group according to completeness of the intervention using t-tests or one-way ANOVAs according to the level of measurement of the variables. Tested using a 2x2 contingency table analysis and the McNemar test statistic.", 
                "measure": "Reduction in anxiety", 
                "safety_issue": "No", 
                "time_frame": "Up to 6 months"
            }, 
            {
                "description": "Compared demographically by group according to completeness of the intervention using t-tests or one-way ANOVAs according to the level of measurement of the variables. Tested using a 2x2 contingency table analysis and the McNemar test statistic.", 
                "measure": "Reduction in depression", 
                "safety_issue": "No", 
                "time_frame": "Up to 6 months"
            }, 
            {
                "description": "Compared demographically by group according to completeness of the intervention using t-tests or one-way ANOVAs according to the level of measurement of the variables.", 
                "measure": "Overall survival", 
                "safety_issue": "No", 
                "time_frame": "At 6 months"
            }, 
            {
                "description": "Two way (2x2) ANOVAs will be conducted to test the differences between groups.", 
                "measure": "Health care resource use including presence of advanced care planning, chemotherapy in the last 14 days of life, and length of time between hospice referral and death", 
                "safety_issue": "No", 
                "time_frame": "Up to 6 months"
            }
        ], 
        "source": "City of Hope Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "City of Hope Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}